SEC Form 4 · accession 0001125345-18-000030
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn Cilinski
Officer — VP, Controller and Treasurer
Period of report
Feb 28, 2018
Accepted (ET)
Mar 1, 2018 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2018 | M | 7,989 | $0.94 | A | 9,912 | D | |
| Common Stock | Feb 28, 2018 | M | 7,989 | $0.94 | A | 17,901 | D | |
| Common Stock | Feb 28, 2018 | M | 7,989 | $1.51 | A | 25,890 | D | |
| Common StockF2 | Feb 28, 2018 | S | 23,967 | $25.0109 | D | 1,923 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) | $0.94 | Feb 28, 2018 | M | 7,989 | D | Jul 9, 2011 | Jan 8, 2021 | Common Stock | 7,989 | 0 | D |
| Employee stock option (right to buy) | $0.94 | Feb 28, 2018 | M | 7,989 | D | Sep 14, 2012 | Mar 13, 2022 | Common Stock | 7,989 | 0 | D |
| Employee stock option (right to buy) | $1.51 | Feb 28, 2018 | M | 7,989 | D | Jul 6, 2013 | Jan 5, 2023 | Common Stock | 7,989 | 0 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2017.
- F2This transaction was executed in multiple trades at prices ranging from $25.00 to $25.14. The price reported above reflects the weighted average sale price on the date indicated. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.